M - BOWEL
Providers must assess and monitor for the unique clinical presentation of gastrointestinal and intra-abdominal complications related to neurogenic bowel dysfunction in individuals with SCI. (PVA-NBD 2020, p.454; Level C)
Providers must assess and monitor for complications that primarily affect areas outside the abdomen but that are related to neurogenic bowel dysfunction, such as AD and skin breakdown. (PVA-NBD 2020, p.454; Level C)
Treatment for hemorrhoids is conservative; if bleeding is refractory, non-excisional techniques are warranted. Excisional hemorrhoidectomy should be avoided. (PVA-NBD 2020, p.454; Level B)